News
-
19 July 2018
SHORT COURSE ON EPIDEMIOLOGY AND BIOSTATISTICS, 20th to 24th August 2018 ,at Uganda Virus Research Institute, Entebbe, Uganda
The Uganda Virus Research Institute through East African Consortium for Clinical Research-HIV node (EACCR2-HIV node) is inviting applications for a short course training on Basic Epidemiology and Biostatistics that will be held from 20th to 24th August 2018 at Uganda Virus Research Institute, Entebbe, Uganda. This is a 5-day long course targeted at young researchers, Medical doctors, laboratory technologists, Masters’ and PhD students who need the skills in basic epidemiology and biostatistics. The course consists of intensive learning sessions and hands on practical sessions in biostatistics delivered by some of the leading biostatisticians and epidemiologists in the field.
-
18 July 2018
LAUNCH OF HATUA RESEARCH CONSORTIUM: 16TH TO 17TH JULY 2018
HATUA, an acronym of Holistic Approach to Unravel Antibacterial Resistance in East Africa, is a consortium of research and academic Institutions from East Africa (Catholic University of Health and Allied Sciences (CUHAS), Kenya Medical Research Institute (KEMRI), Makerere University (MUK), Uganda Virus Research Institute (UVRI), Kilimanjaro Clinical Research Institute (KCRI), NIMR-Mbeya Medical Research Centre (NIMR-MMRC), National Museum of Kenya, Technological University of Mombasa, Busitema University and Mbarara University)
-
12 March 2017
PanACEA kicks off new clinical trials programme for TB-drug evaluation
The EDCTP-funded PanACEA consortium (Pan-African Consortium for the Evaluation of Antituberculosis Antibiotics) who were recently awarded their second EDCTP grant worth almost € 11.4 million (PanACEA2), held a kick-off meeting in Cape Town, South Africa from 7-8 March 2017.
-
18 January 2017
Call for PhD application
The IMPROVE Consortium seeks applicants for the following topics under 4 work packages
-
06 June 2016
KCRI staff meeting on Friday 3rd June,2016 at KCRI
-
13 April 2016
KCRI Strategic Plan (2016- 2026) review meeting
-
08 April 2016
VACANCY ANNOUNCEMENT: Lab Technologist
-
22 March 2016
Career Development Workshop from 16th to 17th and 21st March 2016 at KCMC
The workshop was funded by Wellcome Trust and Bills and Melinda Gates Foundation
-
22 February 2016
TWENDE Meeting at the Kilimanjaro Clinical Research Institute
-
04 February 2016
ZELS PROJECT MEETING -28th Jan - 3rd Feb 2016, KCRI
The meeting involved collaborators from Glasgow, KCRI and Nelson Mandela University
-
13 August 2015
Master of Science thesis defense 29th July 2015
KCRI/KCMU Co
-
13 April 2015
Prof. Dr. Martin Boeree presented MAMS TB 01 trial at CROI 2015
A combination regimen containing high-dose rifampicin (also known as rifampin) was associated with faster tuberculosis (TB) bacteria culture conversion in people with drug-sensitive TB, but moxifloxacin and the experimental drug SQ109 showed no benefit compared to standard therapy, according to results from a study presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2015) in Seattle, USA.
- 1 of 7
- ››